We are driven by a singular purpose to advance the viral vectors contribution to CGT.

We aim to do so through the optimisation of current effective technologies and through our further R&D efforts create new technologies to advance efficacies. In this way we will contribute CGT access to the unmet treatments patients require globally. 

Embrace innovation, collaborate with brilliant minds, and make a real difference. Your expertise could be the key to unlocking a healthier tomorrow. Explore opportunities now!